Optum and Capella University Announce New Nurse Practitioner Program To Address the Growing National Need for Skilled Clinicians

Optum, a diversified health services company, and Capella University, an accredited online university, announced a new educational program designed to address the growing need for skilled, advanced practice nurses. The collaboration will pair Capella’s unique educational capabilities with Optum’s clinical…

Read MoreOptum and Capella University Announce New Nurse Practitioner Program To Address the Growing National Need for Skilled Clinicians

MedReg 2023: Annual Medical Device Regulatory Confex – Where Regulatory Excellence Meets Virtual Engagement – ResearchAndMarkets.com

The “MedReg 2023 – Annual Medical Device Regulatory Confex” training has been added to ResearchAndMarkets.com’s offering. Step into the realm of regulatory excellence at MedReg 2023, the Annual Medical Devices Regulatory Confex that will revolutionize your understanding of medical device regulations. Get ready for…

Read MoreMedReg 2023: Annual Medical Device Regulatory Confex – Where Regulatory Excellence Meets Virtual Engagement – ResearchAndMarkets.com

AGIC Capital Completes Growth Equity Investment into AP Technologies

AGIC Capital (“AGIC”), a growth-oriented European-Asian private equity firm with $2.2 billion of assets under management has completed the investment of an undisclosed amount into AP Technologies (“AP Tech”), an emerging medical device contract manufacturer focusing on highly-engineered solutions for…

Read MoreAGIC Capital Completes Growth Equity Investment into AP Technologies

DermaSensor Study Results For Skin Cancer Detection Device Performance Across Skin Tones Of Over 1,000 Patients

DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin lesions, presented today promising results from a sub-analysis of the DERM-SUCCESS study.1 The analysis focused on the performance of DermaSensor’s handheld Elastic…

Read MoreDermaSensor Study Results For Skin Cancer Detection Device Performance Across Skin Tones Of Over 1,000 Patients

CORRECTING and REPLACING Children’s Health Ireland and Oneview Healthcare partner to deliver Digital Patient Engagement And Education System

Third Paragraph, first sentence of release dated August 10, 2023 should read: Implementation of the Digital Patient Engagement and Education System will commence in Q3 2023. The updated release reads:  CHILDREN’S HEALTH IRELAND AND ONEVIEW HEALTHCARE PARTNER TO DELIVER DIGITAL…

Read MoreCORRECTING and REPLACING Children’s Health Ireland and Oneview Healthcare partner to deliver Digital Patient Engagement And Education System

David Maman and Divya Chander to Keynote CharmHealth Third Annual Innovation Challenge & Showcase

CharmHealth, a leading provider of healthcare technology solutions, today announced that Binah.ai CEO and Founder David Maman and Divya Chander, chair of neuroscience, faculty in medicine at Singularity University, will be the keynote speakers for the 2023 Innovation Challenge. Maman and Chander will address…

Read MoreDavid Maman and Divya Chander to Keynote CharmHealth Third Annual Innovation Challenge & Showcase

Artificial Intelligence and Machine Learning Powered Signal Management Training: A Course for Visionaries – Unlocking the Potential of AI and ML in Drug Safety – ResearchAndMarkets.com

The “Artificial Intelligence and Machine Learning Powered Signal Management Training Course” conference has been added to ResearchAndMarkets.com’s offering. The quest to find precise evidence to answer complex questions from biomedicine and Healthcare for Drug Safety has brought us to a major crossroads. With the…

Read MoreArtificial Intelligence and Machine Learning Powered Signal Management Training: A Course for Visionaries – Unlocking the Potential of AI and ML in Drug Safety – ResearchAndMarkets.com

CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today commented on the issuance of proposed changes to the Local Coverage…

Read MoreCareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection

CAS and Molecule.one Announce Strategic Collaboration to Accelerate Drug Discovery

 CAS is the American Chemical Society’s specialized division for scientific information solutions and Molecule.one is the Leading company in biotechnology. The two institutions have entered into a strategic collaboration focused on the joint development of computer-aided synthetic design techniques to accelerate…

Read MoreCAS and Molecule.one Announce Strategic Collaboration to Accelerate Drug Discovery